Personalizing cardiovascular risk: Coronary artery calcium scans to improve statin use in adults with type 2 diabetes can be cost‐effective in select individuals

Documenti analoghi

• Estimating the risk of cardiovascular outcomes and all‐cause mortality in individuals with type 2 diabetes: Validation of the UKPDS outcomes model using TECOS and EXSCEL data
  di: Ruth L. Coleman, et al.
  Pubblicazione: (2025)
• Use of adjunctive glycaemic agents with vascular protective properties in individuals with type 1 diabetes: Potential benefits and risks
  di: Ahmad M. Rajab, et al.
  Pubblicazione: (2025)
• Lifetime and 10‐year cardiovascular risk prediction in individuals with type 1 diabetes: The LIFE‐T1D model
  di: Marga A. G. Helmink, et al.
  Pubblicazione: (2024)
• Evaluating different low‐density lipoprotein cholesterol thresholds to initiate statin for prevention of cardiovascular diseases in patients with type 2 diabetes mellitus: A target trial emulation study
  di: Eric Yuk Fai Wan, et al.
  Pubblicazione: (2024)
• Sex‐specific associations between haemoglobin glycation index and the risk of cardiovascular and all‐cause mortality in individuals with pre‐diabetes and diabetes: A large prospective cohort study
  di: Jingqi Yang, et al.
  Pubblicazione: (2024)